Acute Urodynamic Effects of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease

被引:68
|
作者
Kabay, Sibel Canbaz [1 ]
Kabay, Sahin [1 ]
Yucel, Mehmet [1 ]
Ozden, Hilmi [1 ]
机构
[1] Dumlupinar Univ, Fac Med, Dept Urol, TR-43100 Kutahya, Turkey
关键词
electrical stimulation; urinary incontinence; urodynamics; neuromodulation; Parkinson's disease; PTNS; CORD-INJURY PATIENTS; ELECTRICAL-STIMULATION; VOIDING DYSFUNCTION; URINARY SYMPTOMS; BLADDER; NEUROMODULATION; VARIABILITY; INSTABILITY; INHIBITION; CYSTOMETRY;
D O I
10.1002/nau.20593
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: Lower urinary tract dysfunction is often occurs in patients with Parkinson's disease (PD), that is primarily induced by neurogenic detrusor overactivity (NDO) and negatively effect the quality of the patient's life. The aim of this study is to evaluate the acute effects of posterior tibial nerve stimulation (PTNS) on the urodynamic findings in the PD patients with NDO. Methods: Thirty-two patients with PD (19 [59.3%] men and 13 [40.6%] women) with NDO were included in the study. Mean age of the patients was 64.2 +/- 8.7 years (range 44-78). Urodynamic studies before and during PTNS were performed. Electrical stimulation was applied unilaterally from the medial malleolus and posterior to the edge of the tibia by using charge-compensated 200 mu sec pulses with a pulse rate of 20 Hz. Mean first involuntary detrusor (1st IDCV) contractions and means maximum cystometric capacity (MCC) before and during PTNS was compared. Results: Mean 1st 1DCV on standard cystometry was 145.2 +/- 41.1 (55-265) ml, while it was 244.7 +/- 51.7 (145-390) ml during PTNS. MCC on standard cystometry was 204.8 +/- 40.5 (115-320) ml, while it was 301.2 +/- 51.5 (230-395) ml during stimulation. Mean 1st IDC and mean MCC were significantly improved during PTNS. Conclusions: These results have demonstrated the objective acute effect of PTNS on urodynamic parameters. PTNS is acutely effective to suppress detrusor overactivity in PD patients. Neurourol. Urodynam. 28:62-67, 2009. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 50 条
  • [31] Detrusor overactivity is associated with frontal dysfunction in patients with Parkinson's disease?
    Uchiyama, T.
    Yamamoto, T.
    Suzuki, K.
    Kadowaki, T.
    Watanabe, Y.
    Hashimoto, K.
    Shingo, T.
    Kaga, K.
    Shibata-Yamaguchi, C.
    Yamanishi, T.
    Sakakibara, R.
    Kuwabara, S.
    Hirata, K.
    MOVEMENT DISORDERS, 2016, 31 : S109 - S109
  • [32] THREE-YEAR FOLLOW-UP OF BOTULINUM TOXIN A INTRADETRUSORIAL INJECTIONS IN PATIENTS WITH PARKINSON'S DISEASE AND REFRACTORY NEUROGENIC DETRUSOR OVERACTIVITY: CLINICAL AND URODYNAMIC RESULTS
    Giannantoni, Antonella
    Proietti, Silvia
    Gubbiotti, Marilena
    De Vermandois, Jacopo A. Rossi
    Porena, Massimo
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 : S10 - S10
  • [33] Semiconditional Electrical Stimulation of Pudendal Nerve Afferents Stimulation to Manage Neurogenic Detrusor Overactivity in Patients with Spinal Cord Injury
    Lee, Young-Hee
    Kim, Jung Moon
    Im, Hyung Tae
    Lee, Kye-Wook
    Kim, Sung Hoon
    Hur, Dong Min
    ANNALS OF REHABILITATION MEDICINE-ARM, 2011, 35 (05): : 605 - 612
  • [34] Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence are Not Due to a Placebo Effect: A Randomized, Double-Blind, Placebo Controlled Trial
    Finazzi-Agro, Enrico
    Petta, Filomena
    Sciobica, Francesco
    Pasqualetti, Patrizio
    Musco, Stefania
    Bove, Pierluigi
    JOURNAL OF UROLOGY, 2010, 184 (05): : 2001 - 2006
  • [35] CLINICAL AND URODYNAMIC EFFECTS OF XEOMIN® IN THE TREATMENT OF REFRACTORY NEUROGENIC DETRUSOR OVERACTIVITY IN SPINAL CORD INJURED PATIENTS: PRELIMINARY RESULTS
    Proietti, S.
    Giovannozzi, S.
    Gubbiotti, M.
    Lepri, E.
    Giannantoni, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 613 - 613
  • [36] Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease
    Finazzi-Agrò, E
    Peppe, A
    D'Amico, A
    Petta, F
    Mazzone, P
    Stanzione, P
    Micali, F
    Caltagirone, C
    JOURNAL OF UROLOGY, 2003, 169 (04): : 1388 - 1391
  • [37] Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment
    Palleschi, Giovanni
    Pastore, Antonio Luigi
    Stocchi, Fabrizio
    Bova, Gino
    Inghilleri, Maurizio
    Sigala, Sandra
    Carbone, Antonio
    CLINICAL NEUROPHARMACOLOGY, 2006, 29 (04) : 220 - 229
  • [38] BOTULINUM TOXIN TYPE-A IN PATIENTS WITH PARKINSON'S DISEASE AND REFRACTORY DETRUSOR OVERACTIVITY
    Giannantoni, A.
    Conte, A.
    Proietti, S.
    Giovannozzi, S.
    Gubbiotti, M.
    Berardelli, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 254 - 254
  • [39] Percutaneous posterior tibial nerve stimulation in patients with chronic pelvic pain: A preliminary study
    Kim, Soo Woong
    Paick, Jae-Seung
    Ku, Ja Hyeon
    UROLOGIA INTERNATIONALIS, 2007, 78 (01) : 58 - 62
  • [40] Mirabegron in the treament of neurogenic detrusor overactivity incontinence in patients with Parkinson's disease: Persistence to treatment in a medium-term follow-up
    Giannantoni, A.
    Gubbiotti, M.
    Valloni, A.
    Croce, F.
    Caponera, M.
    EUROPEAN UROLOGY, 2023, 83 : S984 - S985